The trial location is within the Tweed Valley of New South Wales and was planted in December 2021. A complete cycle of planned silicon treatment application has been carried out in collaboration and support with the grower. A new round of treatments will begin in late November 2022.
As most NSW growers agree, 2022 was a challenging year due to the extended wet and cold periods. A combination of the sub-optimal growing conditions and isolated severe weather events has significantly slowed the growth of the bananas within the trial. The slowed growth reduced the infection rate, resulting in a lag of external symptoms. Our ability to record adequate data for early interpretation has been delayed. As the hotter months begin and growth rates increase, our ability to make accurate observations has improved.
Samples were taken in late September 2022 of suspect disease in plant tissue across the trial. It has been confirmed that Panama disease race 1 has infected the plants uniformly within the trial. This is good news for the trial efficacy. Uniform infection is paramount to measuring the silicon application’s effectiveness and its potential to improve tolerance to Panama disease race 1.
Until March 2023, no external symptoms of Fusarium wilt were present, including the non-treated treatments (no silicon applied) within the trial.
This trial is a joint initiative between the NSW Department of Primary Industries, Southern Cross University, the University of Queensland, Agripower Australia and the Australian Banana Growers’ Council.